natgillin/translations-raw huggingface dataset:
NovoSeven is used to treat bleeding episodes and to prevent excessive bleeding connected with surgery or other invasive procedures: • if you are born with haemophilia and do not respond normally to factors VIII or IX (due to inhibitors to coagulation factors VIII or IX or patients who are at risk of responding to factor VIII or factor IX injection with a rapid and substantial increase in inhibitors against these products) • if you have acquired haemophilia • if you have Factor VII deficiency • if you have Glanzmann’ s thrombasthenia (a bleeding disorder) which can not be treated effectively with platelet transfusion.
NovoSeven se uporablja za zdravljenje krvavitev in preprečevanje čezmernih krvavitev, povezanih z operacijami ali drugimi invazivnimi postopki: • če imate prirojeno hemofilijo in se ne odzivate normalno na faktor VIII ali IX (zaradi zaviralcev koagulacijskih faktorjev VIII ali IX, ali bolniki, pri katerih obstaja tveganje, da se na injiciranje faktorja VIII ali IX odzovejo s hitrim in občutnim povečanjem zaviralcev proti tem zdravilom), • če imate pridobljeno hemofilijo, • če imate pomanjkanje faktorja VII, • če imate Glanzmannovo trombastenijo (motnjo strjevanja krvi), ki je ni mogoče učinkovito zdraviti s transfuzijo trombocitov.
BEFORE YOU USE NOVOSEVEN
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO NOVOSEVEN
Do not use NovoSeven… • if you are allergic to any ingredient in NovoSeven, or • if you are allergic to mouse, hamster or cow proteins
Ne uporabljajte zdravila NovoSeven, • če ste alergični na katero koli sestavino zdravila NovoSeven ali • če ste alergični na mišje, hrčkove ali kravje beljakovine.
Take special care with NovoSeven and make sure your doctor knows... • if you have just had surgery • if you recently had a crush injury • if your arteries are narrowed by disease • if you have severe liver disease • if you have a serious blood infection
Pri uporabi zdravila NovoSeven bodite posebno pozorni in svojemu zdravniku povejte: • če ste bili pred kratkim operirani, • če ste nedavno imeli poškodbo z zmečkanino, • če imate zaradi bolezni zožene arterije, • če imate hudo bolezen jeter, • če imate resno okužbo krvi.
Patients predisposed to disseminate intravascular coagulation (DIC, a condition where blood clots develop throughout the blood stream) should be carefully monitored.
Bolniki, nagnjeni k diseminirani intravaskularni koagulaciji (DIK, stanje, pri katerem povsod v krvnem obtoku nastajajo krvni strdki), potrebujejo natančen nadzor.
89 If bleeding is not kept under control, contact your doctor immediately.
89 Če kaj od tega velja za vas, se posvetujte z zdravnikom, preden uporabite injekcijo.
Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Uporaba drugih zdravil Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katero koli zdravilo, tudi če ste ga dobili brez recepta.
Simultaneous use of NovoSeven and coagulation factor concentrates should be avoided.
Izogibati se je treba sočasni uporabi zdravila NovoSeven in koncentratov koagulacijskih faktorjev.
Experience with simultaneous use of NovoSeven and medicines used to reduce the dissolving of blood clots is limited and if you are taking such medicines you should talk to your doctor before taking NovoSeven.
Če uporabljate takšna zdravila, se morate pred uporabo zdravila NovoSeven posvetovati z zdravnikom.
Pregnancy and breast-feeding If you are pregnant or breast-feeding, ask your doctor for advice before you use NovoSeven.
Nosečnost in dojenje Če ste noseči ali dojite, pred uporabo zdravila NovoSeven za nasvet vprašajte zdravnika.
HOW TO USE NOVOSEVEN
KAKO UPORABLJATI ZDRAVILO NOVOSEVEN
NovoSeven needs to be injected into a vein.
NovoSeven je treba injicirati v veno.
In case of severe bleeds NovoSeven will be administered by a doctor or nurse in the surgery or hospital.
V primeru hude krvavitve bosta NovoSeven dala zdravnik ali medicinska sestra v ambulanti ali bolnišnici.
In case of mild or moderate bleeding episodes, it may be given you to use at home if required.
Za blage ali zmerne krvavitve ga lahko izročijo vam, da ga uporabite doma, če je potrebno.
Do not treat yourself for longer than 24 hours without consulting your doctor: • Each time you use NovoSeven, tell your doctor or hospital at the earliest possible opportunity so that your progress can be monitored • If bleeding is not controlled, you will need hospital care.
Sami se ne smete zdraviti več kot 24 ur, ne da bi se posvetovali z zdravnikom: • Vsakokrat, ko uporabite NovoSeven, o tem čim prej obvestite zdravnika ali bolnišnico, da bo mogoče spremljati vaš napredek. • Če krvavitev ni obvladana, boste potrebovali zdravljenje v bolnišnici.
Dosage The dose will be worked out by your doctor, based on your body weight and your condition.
OdmerjanjeOdmerek bo določil zdravnik na podlagi vaše telesne mase in vašega stanja.
The usual dose is 90 μ g for every 1 kg you weigh, at each injection.
Če imate hemofilijo: običajni odmerek za vsako injekcijo je 90 μg na vsak kilogram telesne mase.
As an alternative your doctor may recommend a single dose of 270 µg for every 1 kg you weigh, however, there is no clinical experience in elderly using this dose.
Kliničnih izkušenj z uporabo tega odmerka pri starejših bolnikih ni.
The home therapy should not exceed 24 hours.
Sami se ne smete zdraviti več kot 24 ur.
The usual dose range is 15 to 30 μ g for every 1 kg you weigh, at each injection.
Če imate pomanjkanje faktorja VII: običajni odmerek za vsako injekcijo je 15 do 30 μg na vsak kilogram telesne mase.
The usual dose is 90 μ g (range is 80 to 120 μ g) for every 1 kg you weigh, at each injection.
Če imate Glanzmannovo trombastenijo: običajni odmerek za vsako injekcijo je 90 μg (razpon od 80 do 120 μg) na vsak kilogram telesne mase.
For all use of NovoSeven • Talk to your doctor about when to use the injections and how long to keep using them • The first dose should be given as early as possible after bleeding has started • Your doctor might change the dose
Za vse primere uporabe zdravila NovoSeven velja: • Z zdravnikom se posvetujte o tem, kdaj uporabiti injekcije in kako dolgo jih uporabljati. • Prvi odmerek je treba dati čim prej po začetku krvavitve. • Vaš zdravnik lahko odmerek spremeni.
If you inject more NovoSeven than you should If you inject too much NovoSeven, get medical advice at once.
Če injicirate večji odmerek zdravila NovoSeven, kot bi smeli Če injicirate preveč zdravila NovoSeven, nemudoma poiščite zdravniški nasvet.
If you forget an injection of NovoSeven If you forget an injection, or if you want to stop the treatment, get your doctor's advice.
Če pozabite injicirati zdravilo NovoSeven Če pozabite injicirati zdravilo ali če želite prenehati zdravljenje, se posvetujte z zdravnikom.
Making up the injection and injecting the solution See overleaf for detailed instructions.
Priprava za injiciranje in injiciranje raztopine Za podrobna navodila glejte naslednjo stran.
Like all medicines, NovoSeven can cause side effects, although not everybody gets them.
90 Kot vsa zdravila ima lahko tudi zdravilo NovoSeven neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
For every 1,000 NovoSeven doses less than one side effect has been reported.
Opisan je bil manj kot en neželen učinek na 1. 000 odmerkov zdravila NovoSeven.
Serious side effects (very rare: affects less than 1 user in 10,000) • Blood clots in arteries leading to heart attack or stroke • Blood clots in veins that can lead to blood clots in the lungs • Blood clots in liver predominantly in patients with liver disease or undergoing liver surgery.
Resni neželeni učinki (zelo redki: pojavijo se pri manj kot 1 od 10. 000 uporabnikov) • krvni strdki v arterijah, ki povzročijo srčni infarkt ali možgansko kap • krvni strdki v venah, ki lahko povzročijo krvne strdke v pljučih • krvni strdki v jetrih, pretežno pri bolnikih z boleznijo jeter ali tistih, ki so prestali operacijo na jetrih
In the vast majority of cases reported, the patients were predisposed to thrombotic disorders due topre-existing risk factors such as recent surgery, recent crush injury, arteries narrowed by disease, liver disease and serious blood infection.
V veliki večini zabeleženih primerov je pri bolnikih obstajala nagnjenost k trombotičnim motnjam zaradi že prej obstoječih dejavnikov tveganja, npr. nedavne operacije, nedavne zmečkaninske poškodbe, bolezensko zoženih arterij, bolezni jeter ali resne okužbe krvi.
Less serious side effects (very rare; affects less than 1 user in 10,000) Rash; Fever; Nausea; Increase in liver enzymes.
Manj resni neželeni učinki (zelo redki: pojavijo se pri manj kot 1 od 10. 000 uporabnikov) izpuščaj, zvišana telesna temperatura, siljenje na bruhanje, zvišanje vrednosti jetrnih encimov
Isolated cases of hypersensitivity reactions including anaphylactic reactions have been reported.
Poročani so bili posamezni primeri preobčutljivostnih in anafilaktičnih reakcij.
Remind your doctor if you have a history of allergic reactions as you may need to be monitored more carefully.
Svojemu zdravniku povejte, če ste kdaj doživeli kakšno alergijsko reakcijo, ker bo zdravljenje morda treba skrbneje spremljati.
HOW TO STORE NOVOSEVEN
SHRANJEVANJE ZDRAVILA NOVOSEVEN
• Keep out of the reach and sight of children • Store NovoSeven in a refrigerator (2°C - 8°C) • Store in original package in order to protect from light • Do not freeze, to prevent damage to the solvent vial • Do not use the product after the expiry date which is stated on the outer carton and labels.
• Zdravilo shranjujte nedosegljivo otrokom! • NovoSeven shranjujte v hladilniku (pri temperaturi med 2 °C in 8 °C). • Shranjujte v originalni ovojnini, da boste zagotovili zaščito pred svetlobo. • Ne zamrzujte, da boste preprečili poškodbo viale z vehiklom. • Zdravila ne uporabljajte po datuma izteka roka uporabnosti, ki je naveden na zunanji ovojnini in nalepkah.
The expiry date refers to the last day of that month. • It is recommended that the product be used immediately following reconstitution.
Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca. • Priporočljivo je, da zdravilo uporabite takoj po pripravi.
However, if not used immediately, storage time and storage conditions prior to use are the responsibility of the user.
Če ni uporabljeno takoj, so čas shranjevanja in pogoji pred uporabo odgovornost uporabnika.
It should not be longer than 24 hours at 2ºC – 8ºC, unless reconstitution has taken place in controlled and validated bacteria-free conditions.
Čas shranjevanja ne sme biti daljši od 24 ur pri temperaturi od 2 do 8 °C, razen če je bila raztopina pripravljena v nadzorovanih in preverjenih pogojih brez bakterij.
What NovoSeven contains • The active substance is recombinant coagulation factor VIIa (activated eptacog alfa). • The other ingredients in the powder are sodium chloride, calcium chloride dihydrate, glycylglycine, polysorbate 80, mannitol, hydrochloric acid, sodium hydroxide and water for injections.
Kaj vsebuje zdravilo NovoSeven • Zdravilna učinkovina je rekombinantni koagulacijski faktor VIIa (aktivirani eptakog alfa). • Pomožne snovi v prašku so natrijev klorid, kalcijev klorid dihidrat, glicilglicin, polisorbat 80, manitol, klorovodikova kislina in natrijev hidroksid.
The powder for solution for injection contains:
Prašek za raztopino za injiciranje vsebuje:
1.2 mg/ vial (corresponding to 60 KIU/ vial), 2.4 mg/ vial (corresponding to 120 KIU/ vial) or 4.8 mg/ vial (corresponding to 240 KIU/ vial).
1, 2 mg/ vialo (ustreza 60 k. i. e. / vialo), 2, 4 mg/ vialo (ustreza 120 k. i. e. / vialo) ali 4, 8 mg/ vialo (ustreza 240 k. i. e. / vialo).
After reconstitution 1 ml of the solution contains 0.6 mg eptacog alfa (activated).
Po pripravi vsebuje 1 ml raztopine 0, 6 mg aktiviranega eptakoga alfa.
What NovoSeven looks like and contents of the pack The powder vial contains white powder and the solvent contains a clear colourless solution.
Izgled zdravila NovoSeven in vsebina pakiranja Viala s praškom vsebuje bel prašek, viala z vehiklom pa bistro in brezbarvno raztopino.
The reconstituted solution for injection is colourless.
Pripravljena raztopina za injiciranje je brezbarvna.
Do not use the reconstituted solution if particle formation or discolouration is noticed.
Pripravljene raztopine ne uporabite, če se v njej pojavijo delci, ali če opazite, da je obarvana.
91 Each NovoSeven pack contains: • 1 vial with white powder (NovoSeven) for solution for injection • 1 vial with solvent (Water for injections) for reconstitution • 1 sterile vial adapter for reconstitution • 1 sterile disposable syringe for reconstitution and administration • 1 sterile infusion set • 2 alcohol swabs.
91 • 1 vialo z vehiklom (voda za injiciranje) za pripravo, • 1 sterilen adapter za vialo za pripravo, • 1 sterilno brizgo za enkratno uporabo, namenjeno za pripravo in apliciranje, • 1 sterilen infuzijski komplet, • 2 alkoholna zloženca.
1.2 mg (60 KIU), 2.4 mg (120 KIU) and 4.8 mg (240 KIU).
1, 2 mg (60 k. i. e.), 2, 4 mg (120 k. i. e.) in 4, 8 mg (240 k. i. e.).
Marketing authorisation holder and manufacturer Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd, Denmark
Imetnik dovoljenja za promet in izdelovalec Novo Nordisk A/ S Novo Allé DK- 2880 Bagsværd, Danska
92 NOVOSEVEN USER INSTRUCTIONS
92 NAVODILA ZA UPORABO NOVOSEVEN
Water vial Plastic cap
alkoholna infuzijski komplet viala s praškom viala z vodo zloženca
Powder vial Plastic cap
plastičen pokrovček gumijasti zamašek
R ubber stopper
plastičen pokrovček gumijasti zamašek
R ubber stopper
igla ovojnica pokrovček
Needle
brizga
Cap
bat
Vial adapter
adapter za vialo vrh
Spike
konica
Bring the NovoSeven powder and water vials to room temperature (but not above 37°C).
NovoSeven (prašek) in vehikel (vodo) ogrejte na sobno temperaturo (vendar ne na več kot 37 °C), npr. tako, da ju držite v rokah.
You can do this by holding them in your hands.
Odstranite plastična pokrovčka z viale s praškom in viale z vodo.
Remove the plastic caps from the two vials.
Če zaščitni pokrovček ne sedi trdno ali ga sploh ni, viale ne uporabite.
If the caps are loose or missing, do not use the vials.
Gumijasta zamaška očistite z alkoholnima zložencema.
A Remove the protective paper from the vial adapter without taking the vial adapter out of the protective cap.
A Z nastavka za vialo odstranite zaščitni papir, vendar nastavka ne vzemite iz zaščitnega pokrovčka.
B Pull the plunger to draw in a volume of air that is equal to the amount of solvent in the solvent vial (ml equals cc on the syringe).
B Izvlecite bat brizge, da boste vanjo potegnili toliko zraka, kolikor je topila v viali s topilom (mililitri ustrezajo oznaki cc na brizgi).
93 Screw the syringe tightly onto the vial adapter on the solvent vial.
C Brizgo trdno privijte na nastavek za vialo, nameščen na viali s topilom.
D Hold the syringe with the water vial upside down and pull the plunger to draw the water into the syringe.
93 D Obrnite na glavo brizgo skupaj z vialo z vodo in potegnite bat nazaj, tako da potegnete vodo v brizgo.
E Remove the empty water vial by tipping the syringe with the vial adapter.
E Odstranite prazno vialo z vodo, tako da nagnete brizgo skupaj z adapterjem za vialo.
F Click the vial adapter, still attached to the syringe, onto the powder vial.
F Vialo s praškom vstavite v adapter za vialo, ki je še vedno na brizgi.
Make sure not to aim the stream of water directly at the NovoSeven powder as this will cause foaming.
Pazite, da ne boste curka topila usmerili neposredno na prašek, ker bi s tem povzročili penjenje.
G Gently swirl the vial until all the powder is dissolved.
G Previdno vrtite vialo, dokler se prašek ne raztopi.
94 Although NovoSeven will be stable for 24 hours after it has been mixed, you should use it at once to avoid infection.
94 Čeprav je NovoSeven stabilen 24 ur po pripravi, ga uporabite takoj, da boste preprečili možnost okužbe.
If you do not use it immediately after mixing, you should store the vial with the syringe still attached in a refrigerator at 2°C to 8°C for no longer than 24 hours.
Če zdravila ne uporabite takoj, je potrebno vialo skupaj z vstavljeno brizgo hraniti v hladilniku pri 2 °C do 8 °C, vendar ne več kot 24 ur.
Do not store the solution without your doctor’ s advice.
Raztopine za injiciranje ne shranjuje, ne da bi se prej posvetovali z zdravnikom.
H Ensure that the plunger is pushed all the way in before turning the syringe upside down (it may have been pushed out by the pressure in the syringe).
H Preden obrnete brizgo na glavo, poskrbite, da bo bat potisnjen do konca (morda ga je pritisk v brizgi nekoliko iztisnil).
I Unscrew the vial adapter with the empty vial.
I Odvijte adapter za vialo skupaj s prazno vialo.
Follow the injection procedure as instructed by your health care professional.
Pri tem se držite navodil za injiciranje, ki ste jih dobili od vašega zdravstvenega osebja.
J Safely dispose of the syringe, vial adapter, vials, infusion set and any unused product as instructed by your health care professional.
J Varno zavrzite brizgo, adapter za vialo, obe viali, infuzijski komplet in morebitno neuporabljeno zdravilo, tako kot vas je o tem poučilo vaše zdravstveno osebje.
NovoSeven 1 mg (50 KIU) powder and solvent for solution for injection NovoSeven 2 mg (100 KIU) powder and solvent for solution for injection NovoSeven 5 mg (250 KIU) powder and solvent for solution for injection
NovoSeven 1 mg (50 k. i. e.) prašek in topilo za raztopino za injiciranje NovoSeven 2 mg (100 k. i. e.) prašek in topilo za raztopino za injiciranje NovoSeven 5 mg (250 k. i. e.) prašek in topilo za raztopino za injiciranje
NovoSeven is used to treat bleeding events and to prevent excessive bleeding connected with surgery or other invasive procedures: • if you are born with haemophilia and do not respond normally to factors VIII or IX (due to inhibitors to coagulation factors VIII or IX or patients who are at risk of responding to factor VIII or factor IX injection with a rapid and substantial increase in inhibitors against these products) • if you have acquired haemophilia • if you have Factor VII deficiency • if you have Glanzmann’ s thrombasthenia (a bleeding disorder) which can not be treated effectively with platelet transfusion.
NovoSeven se uporablja za zdravljenje krvavitev in preprečevanje čezmernih krvavitev, povezanih z operacijami ali drugimi invazivnimi postopki: • če imate prirojeno hemofilijo in se ne odzivate normalno na faktor VIII ali IX (zaradi zaviralcev koagulacijskih faktorjev VIII ali IX, ali bolniki, pri katerih obstaja tveganje, da se na injiciranje faktorja VIII ali IX odzovejo s hitrim in občutnim povečanjem zaviralcev proti tem zdravilom), • če imate pridobljeno hemofilijo, • če imate pomanjkanje faktorja VII, • če imate Glanzmannovo trombastenijo (motnjo strjevanja krvi), ki je ni mogoče učinkovito zdraviti s transfuzijo trombocitov.
Take special care with NovoSeven and make sure your doctor knows... • if you have just had surgery • if you recently had a crush injury • if your arteries are narrowed by disease • if you you have severe liver disease • if you have a serious blood infection
Pri uporabi zdravila NovoSeven bodite posebno pozorni in svojemu zdravniku povejte: • če ste bili pred kratkim operirani, • če ste nedavno imeli poškodbo z zmečkanino, • če imate zaradi bolezni zožene arterije, • če imate hudo bolezen jeter, • če imate resno okužbo krvi.
96 Patients predisposed to disseminate intravascular coagulation (DIC, a condition where blood clots develop throughout the blood stream) should be carefully monitored.
96 Bolniki, nagnjeni k diseminirani intravaskularni koagulaciji (DIK, stanje, pri katerem povsod v krvnem obtoku nastajajo krvni strdki), potrebujejo natančen nadzor.
If bleeding is not kept under control, contact your doctor immediately.
Če krvavitev ni obvladana, se nemudoma posvetujte z zdravnikom.
If any of these apply to you, talk to your doctor before using the injection.
Če kaj od tega velja za vas, se posvetujte z zdravnikom, preden uporabite injekcijo.
Simultaneous use of NovoSeven and coagulation factor concentrates should be avoided.
Zdravila NovoSeven ne uporabljajte sočasno s koncentrati koagulacijskih faktorjev.
Important information about some of the ingredients of NovoSeven If you have been told by your doctor that you have an intolerance to fructose, contact your doctor before taking NovoSeven.
Pomembne informacije o nekaterih sestavinah zdravila NovoSeven Če vam je zdravnik povedal, da imate intoleranco za fruktozo, se z njim posvetujte, preden uporabite zdravilo NovoSeven.
In case of mild or moderate bleeding episodes, it may be given to you to use at home if required.
Za blage ali zmerne krvavitve ga lahko izročijo vam, da ga uporabite doma, če je potrebno.
Do not treat yourself for longer than 24 hours without consulting your doctor: • Each time you use NovoSeven, tell your doctor or hospital at the earliest possible opportunity so that your progress can be monitored. • If bleeding is not controlled, you will need hospital care.
Sami se ne smete zdraviti več kot 24 ur, ne da bi se posvetovali z zdravnikom • Vsakokrat, ko uporabite NovoSeven, o tem čim prej obvestite zdravnika ali bolnišnico, da bo mogoče spremljati vaš napredek. • Če krvavitev ni obvladana, boste potrebovali zdravljenje v bolnišnici.
Dosage The dose will be worked out by your doctor, based on your body weight and your condition.
Odmerjanje Odmerek bo določil zdravnik na podlagi vaše telesne mase in vašega stanja.
The usual dose is 90 μ g for every 1 kg you weigh, at each injection.
Če imate hemofilijo Običajni odmerek za vsako injekcijo je 90 μg na vsak kilogram telesne mase.
The usual dose range is 15 to 30 μ g for every 1 kg you weigh, at each injection.
Če imate pomanjkanje faktorja VII Običajni odmerek za vsako injekcijo je 15 do 30 μg na vsak kilogram telesne mase.
The usual dose is 90 μ g (range is 80 to 120 μ g) for every 1 kg you weigh, at each injection.
Če imate Glanzmannovo trombastenijo Običajni odmerek za vsako injekcijo je 90 μg (razpon od 80 do 120 μg) na vsak kilogram telesne mase.
97 If you forget an injection of NovoSeven If you forget an injection, or if you want to stop the treatment, get your doctor's advice.
97 Če pozabite injicirati zdravilo ali če želite prenehati zdravljenje, se posvetujte z zdravnikom.
Like all medicines, NovoSeven can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo NovoSeven neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
For every 1,000 NovoSeven doses less than one side effect has been reported.
Na vsakih 1. 000 odmerkov zdravila NovoSeven je bil zabeležen manj kot en neželen učinek.
In the vast majority of cases reported, the patients were predisposed to thrombotic disorders due to pre-existing risk factors such as recent surgery, recent crush injury, arteries narrowed by disease, liver disease and serious blood infection.
V veliki večini zabeleženih primerov je pri bolnikih obstajala nagnjenost k trombotičnim motnjam zaradi že prej obstoječih dejavnikov tveganja, npr. nedavne operacije, nedavne zmečkaninske poškodbe, bolezensko zoženih arterij, bolezni jeter ali resne okužbe krvi.
Less serious side effects (very rare: affects less than 1 user in 10,000) Rash; Fever; Nausea; Increase in liver enzymes.
Manj resni neželeni učinki (zelo redki: pojavijo se pri manj kot 1 od 10. 000 uporabnikov) izpuščaj, zvišana telesna temperatura, siljenje na bruhanje, zvišanje jetrnih encimov
• Keep out of the reach and sight of children • Do not use the product after the expiry date which is stated on the outer carton and labels.
• Zdravilo shranjujte nedosegljivo otrokom! • Zdravila ne smete uporabljajte po datumu izteka roka uporabnosti, ki je naveden na zunanji ovojnini in nalepkah.